Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
What is Cancer?02:12

What is Cancer?

15.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
15.4K
Cell Lines01:16

Cell Lines

11.1K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
11.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study Protocol for a Randomized Clinical Trial Investigating the Effect of Reduced Bleomycin in Electrochemotherapy Treatment on Patients with Cutaneous Metastases (The BLESS Trial).

Bioelectricity·2026
Same author

The effect of progressive resistance training on lean soft tissue mass in head and neck cancer patients during concomitant chemoradiotherapy: the DAHANCA 31 randomized controlled trial.

Acta oncologica (Stockholm, Sweden)·2026
Same author

Molecular diversity of mitochondrial autophagy receptors: context-dependent effects in human health and disease.

Cell death discovery·2026
Same author

Methodological guidelines for P2X receptor assays and data interpretation.

Cell death & disease·2026
Same author

Spatial transcriptomic map of the mouse urinary bladder.

Scientific reports·2026
Same author

Inflammatory protein expression patterns in Hashimoto's thyroiditis: a cross-sectional observational study.

Clinical proteomics·2026

Related Experiment Video

Updated: Mar 19, 2026

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells
10:07

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells

Published on: January 7, 2019

8.2K

Difference in Membrane Repair Capacity Between Cancer Cell Lines and a Normal Cell Line.

Stine Krog Frandsen1, Anna K McNeil2, Ivana Novak3

  • 1Center for Experimental Drug and Gene Electrotransfer, Department of Oncology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark.

The Journal of Membrane Biology
|June 18, 2016
PubMed
Summary

Normal cells exhibit superior plasma membrane repair compared to cancer cells, explaining why electroporation therapies are more effective against malignant cells. This study investigated membrane repair mechanisms in various cell lines.

Keywords:
CancerElectroporationIn vitroMembrane repairNormal

More Related Videos

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.9K
Author Spotlight: Studying Brain Endothelial Barrier in Metastatic Cancer Using Impedance-Based Biosensors
09:38

Author Spotlight: Studying Brain Endothelial Barrier in Metastatic Cancer Using Impedance-Based Biosensors

Published on: September 22, 2023

1.1K

Related Experiment Videos

Last Updated: Mar 19, 2026

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells
10:07

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells

Published on: January 7, 2019

8.2K
Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.9K
Author Spotlight: Studying Brain Endothelial Barrier in Metastatic Cancer Using Impedance-Based Biosensors
09:38

Author Spotlight: Studying Brain Endothelial Barrier in Metastatic Cancer Using Impedance-Based Biosensors

Published on: September 22, 2023

1.1K

Area of Science:

  • Cell biology
  • Biophysics
  • Cancer research

Background:

  • Electroporation and other plasma membrane permeabilization therapies show differential efficacy against malignant versus normal cells.
  • The underlying mechanisms for this differential sensitivity are not fully understood.
  • Investigating cellular repair capacity may elucidate these differences.

Purpose of the Study:

  • To determine if differences in plasma membrane repair capacity explain the greater sensitivity of cancer cells to electroporation.
  • To compare the membrane repair kinetics between normal primary cells and various cancer cell lines.

Main Methods:

  • Plasma membrane disruption was induced using laser application in seven cancer cell lines, one immortalized cell line, and one normal primary cell line.
  • Fluorescent dye uptake over time was monitored to assess membrane repair kinetics.
  • Cell viability assays were conducted after electroporation to evaluate treatment efficacy.

Main Results:

  • Normal primary cells demonstrated the slowest rate and lowest level of dye uptake, indicating slower membrane repair.
  • Six of seven cancer cell lines and the immortalized cell line showed significantly faster dye uptake and higher total uptake compared to normal cells.
  • Post-electroporation viability assays confirmed higher survival rates in normal cells (98%) compared to cancer cells (81-88%).

Conclusions:

  • Normal primary cells possess a more effective plasma membrane repair mechanism than malignant and immortalized cells.
  • Enhanced membrane repair in normal cells contributes to their resistance to plasma membrane permeabilization therapies.
  • These findings support the use of electroporation-based therapies for cancer treatment due to their selective targeting of less-efficiently repairing malignant cells.